Equity
€91,698 ▲ 1.0%
LAB@MOND paid out €159,000 in dividends. That is 99% of the 2025 profit.
LAB@MOND
Lifetime
12 annual accounts with figures on one time axispeak €603,491 (2025)
€603,491▲ 1.5%
peak €171,896 (2022)
€159,866▲ 38.0%
peak €93,472 (2020)
€91,698▲ 1.0%
€335,180▼ 2.2%
peak 5.7 FTE (2023)
4.2 FTE▼ 14.3%
Board5 names since 2020
3 directorsBELIV and 2 others
Owners4 names in the annual accounts
30%BELIV and 1 other
Documentsfilings and deeds
17-07-202614 days before the deadline
2025abbreviated format
Result from €115,820 to €159,866Staff from 4.9 FTE to 4.2 FTEDividend €159,000
Key points
from the 2025 annual accountsChecked score
85
Excellent
Financially stronger than 49% of micro companies in other manufacturing (NACE 32)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.3% across 1,141 companies (NACE 32, micro).
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.4%
01-2025: 0.4%● unchanged vs 12-2024
02-2025: 0.4%● unchanged vs 01-2025
03-2025: 0.4%● unchanged vs 02-2025
04-2025: 0.4%● unchanged vs 03-2025
05-2025: 0.4%● unchanged vs 04-2025
06-2025: 0.4%● unchanged vs 05-2025
07-2025: 0.5%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 0.3%▼ -0.2 percentage points vs 07-2025
09-2025: 0.3%● unchanged vs 08-2025
10-2025: 0.3%● unchanged vs 09-2025
11-2025: 0.3%● unchanged vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.4%▲ +0.1 percentage points vs 03-2026
05-2026: 0.4%● unchanged vs 04-2026
06-2026: 0.4%● unchanged vs 05-2026
07-2026: 0.4%● unchanged vs 06-2026
08-2026: 0.3%▼ -0.1 percentage points vs 07-2026lowest value
09-2026: 0.3%● unchanged vs 08-2026lowest value
10-2026: 0.3%● unchanged vs 09-2026lowest value
11-2026: 0.3%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Size: 4.2 FTE, total assets €426,878
lowers risk
Liquidity: current ratio 0.93, cash €86,766
Founded in 2013
Figures for financial year 2025 (filed on 17-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro). It does better than 31% of them on solvency, 26% on liquidity, 93% on profitability and 43% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 5,053 companies had the same profile as LAB@MOND has now. Each dot stands for 13 companies, two years later.
95.9%
were still trading
2.4%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of LAB@MOND itself: 0.3% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 5,053 companies, not a prediction for LAB@MOND. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.93 (0.84 in 2024), below 1. Short-term debt is 74.3% and cash 20.3% of total assets. 78.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
14 days early
2024
13 days early
2023
12 days late
2022
14 days early
2021
16 days early
2020
64 days early
2019
7 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 17 days before the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- Dentco 62.49%equity €4.0m (2024) · 2024 annual accounts of Dentco
- European Dental Group B.V. consolidatesannual accounts 2025
- BELIV 30%score 95equity €494,168 (2025) · 2025 annual accounts of BELIV
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0537280525
1 director appointed, 1 resignation
Resignation: Dentco BV · Permanent representatives: Tommie Van de Velde and Liesbet Cabooter · Appointment: Dentco BV · General meeting of 27-05-2023 · Gazette deed
2 directors appointed, 1 resignation
Change of role: BELIV BV, from director to class B director · Resignation: COPIAS BV · Appointments: Dentco BV (class A director) and Tandarts Alexander Declerck CommV (class A director) · General meeting of 02-11-2021 · Gazette deed
New establishment in Sint-Martens-Latem
Kortrijksesteenweg 26
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| LAB@MOND Antwerp | €426,878 | €603,491 | 21.5% | 4.2 |
| OPTIC BARCHON Blegny | €588,654 | €548,768 | 44.2% | 5.3 |
| ORTHO PRODUCTIONS Boutersem | €688,094 | €600,048 | 88.9% | 5.3 |
| General MediQs Torhout | €684,666 | €467,622 | 67.1% | 5.4 |
| LABO DENTAIRE GUILLITTE Esneux | €438,501 | €510,236 | 50.1% | 5.9 |
| ORTHOPEDIE KESTELYN Oudenaarde | €607,677 | €347,693 | 76.6% | 5 |
| Maison Luc Médical Brussels | €519,574 | €454,471 | 45.1% | 7.3 |
These companies have the same main activity as LAB@MOND: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €439,000 and €688,000, founded between 2010 and 2018.
Official details
Source: KBO- Status
- Active since 01-08-2013Normal situation
- Activity
- Manufacture of medical and dental instruments and suppliesNACE 32500and 1 other
- Joint committee
- 330.03Health institutions and services · annual accounts 2025
- Establishment units
- 2.237.236.3082018 Antwerp, since 01-08-2013
- 2.315.534.2139830 Sint-Martens-Latem, since 01-04-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 01-12-2025
Annual accounts 2025
- ≈ €1.4mestimated
- €426,878▼ 1.6%
- Employeeson 31-12-2025
- 4=
- Filing
- Filed on 17-07-2026, 14 days before the end of the filing period
Companies linked to LAB@MOND
Parent and group
Insights on LAB@MOND
LAB@MOND files the abbreviated format. That format states no turnover. The gross margin rose from €36,271 in 2014 to €603,491 in 2025.
Dentco holds 62.49% of the shares. In November 2021, the Official Gazette published the appointment of BELIV as managing director.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about LAB@MOND
- What is the company number of LAB@MOND?
- The company number of LAB@MOND is 0537.280.525. The VAT number is the same number with BE in front: BE 0537.280.525.
- Where is LAB@MOND based?
- The registered office is at Pater Pirestraat 50, 2018 Antwerp.Company details
- What does LAB@MOND do?
- According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
- What is the legal form of LAB@MOND?
- LAB@MOND is a private limited company (BV).
- When was LAB@MOND founded?
- LAB@MOND was founded on 01-08-2013.
- Is LAB@MOND still active?
- Yes, LAB@MOND is an active enterprise in the KBO register.
- How many employees does LAB@MOND have?
- LAB@MOND had an average of 4.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does LAB@MOND fall under?
- In its 2025 annual accounts, LAB@MOND states joint committee 330.03 (Health institutions and services).
- What is the turnover of LAB@MOND?
- The turnover in financial year 2025 is ≈ €1.4m. This figure is estimated from the gross margin of €603,491 and 2,275 comparable companies of the same size. It probably lies between €860,000 and €2.4m. It is a rough estimate.
- Is LAB@MOND profitable?
- In financial year 2025, LAB@MOND made a profit of €159,866.
- Where can I find the annual accounts of LAB@MOND?
- LAB@MOND filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LAB@MOND due?
- LAB@MOND must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.EDG België Holding · 18 companies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.